期刊論文:
Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells. Pan Y， Chiu YH， Chiu SC， Cho DY， Lee LM， Wen YC， Whang-Peng J， Hsiao CH， Shih PH. Anticancer Res. 2020 Sep;40(9):5221-5227.
Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells. Pan Y， Chiu YH， Chiu SC， Cho DY， Lee LM， Wen YC， Whang-Peng J， Hsiao CH， Shih PH. Anticancer Res. 2020 Jul;40(7):3865-3872.
Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study. Pan Y， Lee CY， Lee LM， Wen YC， Huang JY， Yang SF， Hsiao CH. Medicina (Kaunas). 2020 Aug 31;56(9):441.
Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells. Pan Y， Chiu YH， Chiu SC， Cho DY， Lee LM， Wen YC， Whang-Peng J， Hsiao CH， Shih PH. Anticancer Res. 2020 Nov;40(11):6093-6099.
Malakoplakia and xanthogranulomatous pyelonephritis treated with nephrectomy: A case report. Pan Y， Hong YC， Shih HJ， Chang CP， Huang SH， Wu SC， Lee LM， Wen YC， Hsu CC， Hsiao CH. Medicine (Baltimore). 2021 Sep 10;100(36):e27137.
Effects of Concurrent Chemoradiotherapy on the Metastasis and the Mesenchymal Transition of Bladder Urothelial Carcinoma Cells. Pan Y， Hong YC， Hsiao CH， Shih HJ， Huang SH， Wu SC， Chang CP， Chiu SC， Cho DY， Shih PH. Anticancer Res. 2021 Oct;41(10):4957-4968.
Synergistic Benefit of Adoptive T Cells in Combination With Chemoradiotherapy Against Metastatic Prostate Cancer Cells. Shen YC, Shih HJ, Lin CC, Huang SH, Wu SC, Hsiao CH, Chiu SC, Cho DY, Chang CP, Pan Y, Shih PH. Anticancer Res. 2022 Jul;42(7):3427-3434.
